Kim Forest Enterprise Co., Ltd.

6645 · TW · Healthcare / Diagnostics & Research

12.75TWD+0.05 (+0.39%)

Price History

Full chart

Market Stats

Previous Close12.70

Open13.40

Day Range12.75 – 13.40

52-Week Range11.40 – 26.45

Volume21.41K

Market Cap772.92M

P/E (TTM)0.00

Forward P/E0.00

EPS-2.24

Dividend Yield0.00%

Beta-0.03

50-Day Avg12.85

200-Day Avg14.58

About

Kim Forest Enterprise Co., Ltd. provides various genetic and medical testing services in China and the United States. The company provides genetic testing, drug report, and monitoring tools for cancer patients; and GoL Life that provides a non-invasive genome-wide health assessment for healthy persons. It offers bioinformatics service items; prenatal test kits; and genetically modified models. In addition, the company offers SARS-CoV-2 detection kits. Further, it engages in the wholesale of medical instruments and consumables; and provision of various genetic and medical testing services. The company was founded in 2004 and is headquartered in New Taipei City, Taiwan.

Company Details

SectorHealthcare
IndustryDiagnostics & Research
CEODaniel Huang
HeadquartersNo. 97, Xintai 5th Road, New Taipei City, Taiwan, 22175, Taiwan
Websitehttps://www.kimforest.com

Leadership

Daniel HuangChief Executive officer
Xiuping ChenFinance Manager
Qian Qi LinAccounting Supervisor
Ming Xi XiaoChief Research and Development Officer
Wen Lan XuHead of Corporate Governance

Financials

Income Statement

Currency: TWD	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	188.37M	268.08M	262.25M	264.27M	231.78M	270.56M	302.90M	600.67M	670.59M	415.01M	501.53M	549.14M
Growth (%)	-	+42.32%	-2.17%	+0.77%	-12.30%	+16.73%	+11.95%	+98.31%	+11.64%	-38.11%	+20.85%	+9.49%
Cost of Revenue	142.63M	209.66M	203.50M	193.34M	186.83M	218.92M	223.59M	341.20M	416.64M	336.40M	445.30M	477.39M
Gross Profit	45.74M	58.41M	58.76M	70.93M	44.95M	51.64M	79.30M	259.47M	253.95M	78.61M	56.23M	71.75M
Gross Margin	24.28%	21.79%	22.40%	26.84%	19.39%	19.08%	26.18%	43.20%	37.87%	18.94%	11.21%	13.07%
Operating Expense	39.54M	42.52M	49.55M	59.56M	80.76M	91.99M	112.59M	146.49M	180.88M	204.44M	226.96M	214.21M
Operating Income	6.20M	15.89M	9.20M	11.38M	-35.81M	-40.36M	-33.29M	112.98M	73.07M	-125.83M	-170.73M	-142.46M
Operating Margin	3.29%	5.93%	3.51%	4.30%	-15.45%	-14.92%	-10.99%	18.81%	10.90%	-30.32%	-34.04%	-25.94%
EBITDA	7.86M	16.91M	17.18M	18.36M	-25.25M	-23.30M	-15.61M	141.00M	97.63M	-72.68M	-103.29M	-74.34M
EBITDA Margin	4.17%	6.31%	6.55%	6.95%	-10.89%	-8.61%	-5.15%	23.47%	14.56%	-17.51%	-20.60%	-13.54%
Net Income	2.08M	10.08M	9.55M	8.83M	-30.72M	-31.87M	-26.15M	89.44M	42.41M	-102.47M	-159.88M	-146.45M
Net Income Margin	1.10%	3.76%	3.64%	3.34%	-13.25%	-11.78%	-8.63%	14.89%	6.33%	-24.69%	-31.88%	-26.67%
R&D	127.00K	4.84M	6.22M	4.70M	16.25M	19.21M	26.70M	21.62M	18.68M	26.89M	26.25M	27.44M
R&D as % of Total Revenue	0.07%	1.80%	2.37%	1.78%	7.01%	7.10%	8.81%	3.60%	2.79%	6.48%	5.23%	5.00%
Interest Expense	4.15M	3.61M	3.02M	2.74M	3.02M	3.91M	2.48M	1.35M	1.93M	2.83M	5.92M	8.22M
Interest Expense % of Total Revenue	2.20%	1.35%	1.15%	1.04%	1.30%	1.45%	0.82%	0.23%	0.29%	0.68%	1.18%	1.50%

Balance Sheet

Currency: TWD	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	263.17M	267.62M	321.78M	325.20M	462.53M	516.94M	503.65M	594.21M	742.81M	846.83M	970.12M	1.14B	1.02B
Total Liabilities	230.68M	184.30M	205.67M	171.91M	188.23M	278.04M	296.62M	143.38M	200.95M	264.55M	392.20M	503.22M	503.64M
Total Equity	32.49M	83.32M	116.11M	153.30M	274.30M	238.91M	207.03M	450.83M	541.69M	582.27M	577.92M	636.04M	490.86M
Cash	5.38M	11.75M	24.89M	38.50M	46.38M	49.47M	26.67M	86.57M	180.99M	125.45M	186.78M	217.86M	123.74M
Total Debt	152.90M	160.86M	158.88M	123.92M	128.55M	214.41M	230.55M	52.38M	106.18M	130.67M	218.89M	366.60M	385.51M
Net Debt	147.52M	149.11M	133.99M	85.41M	82.17M	164.94M	203.89M	-34.19M	-74.80M	5.22M	32.11M	148.75M	261.76M

Cash Flow

Currency: TWD	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	4.10M	23.49M	17.10M	-44.08M	-8.32M	-21.50M	-24.70M	89.70M	52.95M	-64.54M	-170.75M	-56.56M
Investing Cash Flow	-12.03M	-31.91M	12.15M	-69.69M	-73.29M	-13.75M	2.32M	-15.99M	-109.05M	-42.87M	-98.33M	-40.27M
Financing Cash Flow	14.30M	21.56M	-15.64M	121.64M	84.70M	12.45M	82.34M	20.75M	281.00K	168.87M	299.93M	2.85M
Capital Expenditure	8.74M	31.23M	1.82M	67.22M	57.37M	8.40M	463.00K	8.71M	110.32M	36.77M	99.45M	57.83M
Free Cash Flow	-4.64M	-7.75M	15.29M	-111.30M	-65.69M	-29.90M	-25.16M	80.99M	-57.37M	-101.31M	-270.20M	-114.39M
Dividends Paid	254.00K	80.00K	700.00K	806.00K	3.97M	-	-	-	7.75M	4.03M	-	-
FCF to OCF	-113.11%	-32.99%	89.38%	252.50%	789.46%	139.10%	101.87%	90.29%	-108.35%	156.97%	158.25%	202.23%
Dividend Paid to FCF	-5.47%	-1.03%	4.58%	-0.72%	-6.04%	-	-	-	-13.51%	-3.98%	-	-

Key Statistics & Ratios

Market Cap772.92M

Enterprise Value1.13B

Trailing P/E0.00

Forward P/E0.00

Price / Sales1.29

Price / Book1.80

EPS-2.24

Book Value6.95

Revenue (TTM)599.63M

Gross Profit (TTM)95.23M

EBITDA-84.40M

Profit Margin-22.63%

Operating Margin-22.44%

Return on Equity-28.48%

Return on Assets-8.28%

Shares Outstanding60.38M

Shares Float45.44M

Beta-0.03

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20231×

0.09Jun 20, 2023

20221×

0.20Jul 26, 2022

20181×

0.12Jul 24, 2018

Stock Splits

Jul 16, 20241050:1000
Jun 20, 20231145995.6:1000000
Jul 26, 20221316875:1000000
Aug 19, 20211047.297:1000
Jul 16, 20191017.435:1000
Jul 24, 20181020:1000